Ethiopia Country Program
Request for information (RFI) for Pharmaceutical and Medical Supplies
Reference: IRC/ETH/RFI/PHARMA/2026
Publish date: February 22, 2026
Deadline to Respond: March 2, 2026
Interested Pharmaceutical and Medical Suppliers are strongly advised to read through the entire Request for information document before submitting their responses
- Background
The International Rescue Committee, hereinafter referred to as “the IRC”, is a non-profit, humanitarian agency that provides relief, rehabilitation, protection, resettlement services, and advocacy for refugees, displaced persons and victims of oppression and violent conflict.
The IRC-Ethiopia Program has been working in Ethiopia since 1999 and is implementing integrated, community-managed programs aimed at improving the quality of life and recovery of livelihoods for disaster-affected populations through promoting individual participation, strengthening institutions, and enhancing emergency response.
IRC Ethiopia Program has been operating in Gambella, Benishangul Gumuz, Tigray, SNNPR, Sidama, Somali, and Oromia regions on refugee assistance and livelihood since its inception.
Categories:
- Medicines, Medical Supplies & Consumables
- Medical Equipment & Surgical Instruments
- Laboratory reagents & supplies
- Cold chain commodities – Lab reagents
2. Request for Information Objective
The objective of the RFI is to identify and shortlist Pharmaceutical and Medical Suppliers who have capacity and experience in supplying the pharmaceuticals, medicals supplies and equipment in Ethiopia. The IRC intends to have a database in place from which further selection will be made depending on the requirement. The prequalification is valid for 2 years after which it may be repeated.
3. Scope of Work – Technical Requirement/Evaluation Criteria
| Evaluation CRITERIA | DESCRIPTION | WEIGHT (%) |
| Eligibility | Refers to Company ability to demonstrate that they have: Valid certificate of Registration as an Importer, wholesale distributor and Supplier of medical supplies with the Ethiopia Government/EFDA Valid Trade Registration,Valid Business License Valid Tax Registration Certificate Valid Certificate of Operation (Operation license) Valid Import Registration Certificate (if applicable) Product catalog or specifications. Delivery timelines and capacity Evidence of past performance in similar supply contracts and a minimum of 3 recommendations Supplier Information form, completed and signed and stamped clearly stating the contact address | PASS Or FAIL Pass: proceed to the next evaluation process Fail: Not to proceed with the next evaluation step. |
| Documented drug supply Experience | · The bidder must demonstrate proven experience and technical expertise relevant to the required services, including previous work with IRC, other International NGOs, UN Agencies, and Government Institutions. · The bidder shall submit a minimum of three (3) supporting documents evidencing the successful completion of comparable high‑value orders involving a diverse range of pharmaceutical categories within the last six (6) months. Acceptable proof includes signed contracts, delivery notes, and purchase orders. Additionally, the bidder must provide contact information for at least three (3) client organizations/INGOs for reference verification. | 20% |
| Technical specifications | · The supplier shall complete and submit the detailed product information in the Quality Comparison (QCT) (Annex B), clearly indicating all available pharmaceutical categories, including medicines, medical supplies, medical equipment, and laboratory reagents. · The supplier’s storage facility must be clean, well‑organized, and compliant with appropriate storage conditions. Temperature and humidity must be routinely monitored and recorded. Suppliers are required to attach the last three (3) months of temperature and humidity logs, along with recent photographs of the storage area. · The supplier must provide at least five (5) sample copies of ISO and GMP certificates from approved manufacturers in the country of origin, corresponding to products previously supplied to INGOs. . | 30% |
